Skip to main content

FMS

Stock
Health Care
Medical Care Facilities

Performance overview

FMS Price
Price Chart

Forward-looking statistics

Beta
0.61
Risk
28.39%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.

Company info

SectorHealth Care
IndustryMedical Care Facilities
Employees122K
Market cap$12.5B

Fundamentals

Enterprise value$22.7B
Revenue$22.9B
Revenue per employee
Profit margin3.17%
Debt to equity69.92

Security info

ExchangeNyse American
Type of shareADR
Earnings per share (EPS)$1.25
Dividend per share$2.54
Revenue per share$33.22
Avg trading volume (30 day)$10M
Avg trading volume (10 day)$9M
Put-call ratio

Macro factor sensitivity

Growth+0.2
Credit-10.3
Liquidity+3.4
Inflation+0.0
Commodities+0.4
Interest Rates-1.1

Valuation

Dividend yield9.02%
PEG Ratio10.73
Price to sales0.85
P/E Ratio10.73
Enterprise Value to Revenue0.99
Price to book0.57

Upcoming events

Next earnings dayNovember 3, 2025
Next dividend day
Ex. dividend dayMay 23, 2025

News

FMS or SONVY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Fresenius (FMS) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research (July 21, 2025)
Why Fresenius (FMS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research (July 11, 2025)
Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency

Fresenius Medical Care AG FMS on Tuesday introduced a strategic roadmap — FME Reignite — aimed at revitalizing its core business, driving innovation and reshaping its organizational culture.

Benzinga (June 17, 2025)
BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.

CNBC Television (April 9, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free